Occidental Asset Management LLC Invests $296,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Occidental Asset Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 567 shares of the medical equipment provider's stock, valued at approximately $296,000.

Other hedge funds have also made changes to their positions in the company. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical in the third quarter worth approximately $558,807,000. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp boosted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the business's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the firm's stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Stock Up 1.5 %

Shares of NASDAQ:ISRG traded up $8.56 during trading on Friday, hitting $592.64. 2,630,118 shares of the stock traded hands, compared to its average volume of 1,158,623. The company has a fifty day moving average price of $540.66 and a two-hundred day moving average price of $498.77. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $597.68. The company has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have commented on ISRG shares. Robert W. Baird increased their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. Truist Financial lifted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a "buy" rating in a report on Wednesday, December 18th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Raymond James boosted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research note on Monday, October 14th. Finally, BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.